EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Toll‐Like Receptor–Driven Neuroinflammation in Neurological Disorders: Signaling Crosstalk and Therapeutic Opportunities

Akhil Sharma, Gurkirat Singh, Ashi Mannan iD, Vetriselvan Subramaniyan iD, Kamal Dua iD, Thakur Gurjeet Singh iD

Journal of Neuroscience Research · 2026-11 · 104 (11)

DOI: 10.1002/jnr.70171 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuroscience Research, online erschienen am 15.11.2026. Verfasst von Akhil Sharma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chitkara College of Pharmacy, Chitkara University, Rajpura, India. Hauptthemen laut MEDLINE: Neuroinflammatory Diseases, Toll-Like Receptors, Signal Transduction, Nervous System Diseases. Die Arbeit nennt 502 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toll‐like receptors (TLRs) serve as pivotal mediators bridging innate immunity and neuroinflammation, orchestrating pathological cascades that drive neurological disorders. Beyond their sentinel role in pathogen recognition, aberrant TLR activation triggers intricate and destructive signaling networks, including activation of NF‐κB, MAPK, JAK/STAT, and PI3K/AKT, alongside IRFs and type I interferon responses that converge on chronic neuroinflammation and subsequent neuronal damage. This review dissects TLRs' multilayered contribution to neuropathology, emphasizing their regulation of secondary inflammatory mechanisms, including NLRP3 inflammasome priming and activation, mTOR‐driven metabolic dysregulation, SOCS‐mediated feedback inhibition, inflammasome activation, and pyroptotic cell death. Critically, these signaling pathways create a pathological intersection with oxidative stress and mitochondrial dysfunction, amplifying a self‐perpetuating cycle of neuronal injury that underlies conditions like Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and Amyotrophic lateral sclerosis (ALS), Stroke, Multiple sclerosis (MS), Epilepsy and Traumatic brain injury (TBI). Against this neuropathological landscape, this review systematically evaluates emerging therapeutic strategies targeting TLR‐mediated neuroinflammation, encompassing small molecule TLR antagonists, intracellular adaptor protein inhibitors targeting myeloid differentiation primary response 88 (MyD88) and TIR‐domain‐containing adapter‐inducing interferon‐β (TRIF), biologic therapies including monoclonal antibodies and fusion proteins, natural phytochemicals and nutraceuticals, Clustered regularly interspaced short palindromic repeats (CRISPR)‐based genomic interventions, and cell‐based immunomodulatory therapies, collectively representing a mechanistically diverse arsenal aimed at recalibrating the dysregulated innate immune response to achieve durable neuroprotection across the full spectrum of TLR‐mediated neurological disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroinflammatory DiseasesToll-Like ReceptorsSignal TransductionNervous System DiseasesHumansAnimals

Stichwörter der Autor:innen

Toll‐like‐receptors (TLRs)innate immunityneurodegenerationneuroinflammationneuroprotection

Substanzen

Toll-Like Receptors

Autor:innen und Institutionen

  • Chitkara College of Pharmacy, Chitkara University, Rajpura, India.
  • Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Malaysia.
  • NICM Health Research Institute and School of Science, Western Sydney University, Westmead, New South Wales, Australia.

ORCID-Profile: Ashi Mannan, Vetriselvan Subramaniyan, Kamal Dua, Thakur Gurjeet Singh

Zitieren

APA

Sharma, A., Singh, G., Mannan, A., Subramaniyan, V., Dua, K., & Singh, T. G. (2026). Toll‐Like Receptor–Driven Neuroinflammation in Neurological Disorders: Signaling Crosstalk and Therapeutic Opportunities. Journal of Neuroscience Research, 104(11). https://doi.org/10.1002/jnr.70171

Vancouver

Sharma A, Singh G, Mannan A, Subramaniyan V, Dua K, Singh TG. Toll‐Like Receptor–Driven Neuroinflammation in Neurological Disorders: Signaling Crosstalk and Therapeutic Opportunities. Journal of Neuroscience Research. 2026;104(11). doi:10.1002/jnr.70171

BibTeX
@article{Sharma2026,
  author = {Sharma, Akhil and Singh, Gurkirat and Mannan, Ashi and Subramaniyan, Vetriselvan and Dua, Kamal and Singh, Thakur Gurjeet},
  title = {Toll‐Like Receptor–Driven Neuroinflammation in Neurological Disorders: Signaling Crosstalk and Therapeutic Opportunities},
  journal = {Journal of Neuroscience Research},
  year = {2026},
  volume = {104},
  number = {11},
  doi = {10.1002/jnr.70171}
}
Kostenlos starten →